The effect of zinc supplement on control status of diabetes in diabetic Patients

Evaulation of the effect of zinc supplement on control status of diabetes in diabetic patients

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT138812212676N2

Enrollment

Registered

2010-06-19

Start date

2008-04-20

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes. Diabetes mellitus

Interventions

Intervention 1: Zinc sulphate, 50 Mg oral capsule, One capsule every other day for 2 month. Intervention 2: Zinc sulphate, 50 Mg oral capsule, One capsule every day for 2 month.

Treatment - Drugs

Zinc sulphate, 50 Mg oral capsule, One capsule every other day for 2 month

Zinc sulphate, 50 Mg oral capsule, One capsule every day for 2 month

Eligibility

Sex/Gender

All

Age

40 Years to 61 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: Age 40-60, HbA1c greater than 7, TG Less than 400 mg/dl, Cho Less than 250 mg/dl . Exclusion criteria: Smoking, using antioxidant drug, using insulin and renal disease

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
HbA1C. Timepoint: 1 Month prior to intervention, 2 Month after intervention. Method of measurement: Cell counter instrument.	—

Secondary

Measure	Time frame
Fasting blood sugar and 2 hours postprandial. Timepoint: 1 Month prior to intervention, 2 Month after intervention. Method of measurement: Photometer instrument.;Serum Zinc level. Timepoint: 1 Month prior to intervention, 2 Month after intervention. Method of measurement: ELIZA.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactRobab Sheikhpour

Azad University

Sheikhpour_r@yahoo.com+98 35 1623 5958

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026